• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2019)
Bahnasy, N. (2020). EPIDERMAL GROWTH FACTOR GENE POLYMORPHISM IN CIRRHOTIC HEPATITIS C VIRUS PATIENTS WITH HEPATOCELLULER CARCINOMA. ALEXMED ePosters, 2(2), 76-76. doi: 10.21608/alexpo.2020.52927.1082
Nehal Elsayed Bahnasy. "EPIDERMAL GROWTH FACTOR GENE POLYMORPHISM IN CIRRHOTIC HEPATITIS C VIRUS PATIENTS WITH HEPATOCELLULER CARCINOMA". ALEXMED ePosters, 2, 2, 2020, 76-76. doi: 10.21608/alexpo.2020.52927.1082
Bahnasy, N. (2020). 'EPIDERMAL GROWTH FACTOR GENE POLYMORPHISM IN CIRRHOTIC HEPATITIS C VIRUS PATIENTS WITH HEPATOCELLULER CARCINOMA', ALEXMED ePosters, 2(2), pp. 76-76. doi: 10.21608/alexpo.2020.52927.1082
Bahnasy, N. EPIDERMAL GROWTH FACTOR GENE POLYMORPHISM IN CIRRHOTIC HEPATITIS C VIRUS PATIENTS WITH HEPATOCELLULER CARCINOMA. ALEXMED ePosters, 2020; 2(2): 76-76. doi: 10.21608/alexpo.2020.52927.1082

EPIDERMAL GROWTH FACTOR GENE POLYMORPHISM IN CIRRHOTIC HEPATITIS C VIRUS PATIENTS WITH HEPATOCELLULER CARCINOMA

Article 44, Volume 2, Issue 2, October 2020, Page 76-76  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2020.52927.1082
View on SCiNiTO View on SCiNiTO
Author
Nehal Elsayed Bahnasy email
Department of Tropical Medicine, Faculty of Medicine, Alexandria University
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and develops predominately in individuals with liver cirrhosis. HCC represents the second leading cause of cancer-related deaths.
Unlike most malignancies, the major risk factors for HCC development are well-defined. These risk factors are chronic HCV and HBV infections, liver cirrhosis, heavy alcohol intake, tobacco smoking, exposure to environmental and dietary carcinogens (i.e., aflatoxin B1), genetic and metabolic liver disease (i.e., hereditary hemochromatosis, non-alcoholic steatohepatitis), and other conditions capable of inducing liver damage. Moreover, the prevalence of HCC increases with age and male sex.
In addition to environmental factors, recent insights into the biology of HCC have demonstrated that accumulations of genetic and epigenetic abnormalities can also play an essential role in liver carcinogenesis.
Epidermal growth factor (EGF) was first isolated in 1962. It stimulates proliferation, differentiation and tumorigenesis of epidermal and epithelial tissues by binding to its receptor (EGFR) and, hence, activating several signal pathways. EGF is a mitogen for adult and fetal hepatocytes grown in culture, and its expression is up-regulated during liver regeneration.
Keywords
HCC; HCV; EGF
Statistics
Article View: 131
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.